Company intelligence / Profile preview

Everbright

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Everbright Health operates a commercial, tech-enabled services platform that embeds complete clinical programs for FDA-approved advanced psychiatric interventions such as transcranial magnetic stimulation (TMS) and esketamine (SPRAVATO) into community mental health practices, handling infrastructure, staffing, patient identification, prior authorization, treatment workflows, and revenue cycle management for providers across multiple U.S. markets.[7][4]

Therapeutic areas: Psychiatry
Modalities: DeviceNon-pharmacological therapy
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Provider partnerships with over 75 behavioral health practices across seven U.S. markets for delivery of TMS and SPRAVATO programs[7][4]Incubation and strategic partnership with W Health Ventures[7][4]

Beyond the preview

Go deeper on Everbright.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Everbright.

Explore the full profile